Pricing Log in Create free account

TuHURA Biosciences, Inc. (HURA) vs Voyager Therapeutics, Inc. (VYGR)

TuHURA Biosciences, Inc. and Voyager Therapeutics, Inc. are both Biotechnology companies. TuHURA Biosciences, Inc. and Voyager Therapeutics, Inc. are of similar size ($106.0M and $102.6M). TuHURA Biosciences, Inc. has the higher net margin (0.00% vs −416.3%) and the higher return on invested capital (−74.2% vs −249.6%). Across the 14 metrics below, TuHURA Biosciences, Inc. leads on 8 and Voyager Therapeutics, Inc. on 6.

Valuation

Metric HURA VYGR Biotechnology median
P/E n/m n/m 10.60
P/S n/m 4.68 9.40
P/B 5.72 0.87 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 0.42 9.02
Earnings yield (33.13%) (91.58%) (32.88%)
Free cash flow yield (28.71%) (93.67%) (23.13%)

Profitability

Metric HURA VYGR Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (450.12%) 0.00%
Net margin 0.00% (416.32%) 0.00%
Free cash flow margin 0.00% (434.88%) 0.00%
Return on equity (163.84%) (58.90%) (51.96%)
Return on assets (92.31%) (44.92%) (46.06%)
Return on invested capital (74.20%) (249.55%) 0.00%

Growth

Metric HURA VYGR Biotechnology median
Revenue growth (TTM) — (19.82%) 6.76%
EPS growth (last fiscal year) 47.93% (80.53%) 29.88%
Revenue growth, 5-year CAGR — (25.09%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HURA VYGR Biotechnology median
Debt to equity 0.47 0.00 0.00
Current ratio 0.18 6.81 4.97
Net debt to EBITDA 0.12 1.50 1.01

Dividend

Metric HURA VYGR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric HURA VYGR Biotechnology median
Market cap 102.60m 105.99m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack